Literature DB >> 18636225

Telomeric nucleosomes: forgotten players at chromosome ends.

S Pisano1, A Galati, S Cacchione.   

Abstract

Telomeres are the special nucleoprotein structures that protect chromosome ends from both recombination and degradation. In most organisms, telomeric DNA consists of short sequences repeated in tandem ending in single-stranded G-rich overhangs. In higher eukaryotes, about 80% of telomeric DNA is organized in tightly packed nucleosomes separated by 10-20 bp of linker DNA. Several specific proteins contribute to telomeric structure. At the moment, a satisfactory description of telomere organization is still lacking. Whereas the role played by telomeric proteins in telomere function and regulation has been widely investigated, little is known about the contribution of nucleosomes to the protection of chromosome ends. In this review we present an overview on the chromatin organization in lower and higher eukaryotes, and discuss the recent results on the peculiar features of telomeric nucleosomes and on the epigenetic status of mammalian telomeres.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636225     DOI: 10.1007/s00018-008-8307-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  Hyper telomere recombination accelerates replicative senescence and may promote premature aging.

Authors:  R Tanner Hagelstrom; Krastan B Blagoev; Laura J Niedernhofer; Edwin H Goodwin; Susan M Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

2.  Columnar structure of human telomeric chromatin.

Authors:  Aghil Soman; Sook Yi Wong; Nikolay Korolev; Wahyu Surya; Simon Lattmann; Vinod K Vogirala; Qinming Chen; Nikolay V Berezhnoy; John van Noort; Daniela Rhodes; Lars Nordenskiöld
Journal:  Nature       Date:  2022-09-14       Impact factor: 69.504

Review 3.  Telomeres, histone code, and DNA damage response.

Authors:  S Misri; S Pandita; R Kumar; T K Pandita
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

4.  TERRA, hnRNP A1, and DNA-PKcs Interactions at Human Telomeres.

Authors:  Phuong N Le; David G Maranon; Noelia H Altina; Christine L R Battaglia; Susan M Bailey
Journal:  Front Oncol       Date:  2013-04-17       Impact factor: 6.244

5.  TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner.

Authors:  Alessandra Galati; Frédérique Magdinier; Valentina Colasanti; Serge Bauwens; Sébastien Pinte; Ruggero Ricordy; Marie-Josèphe Giraud-Panis; Miriam Caroline Pusch; Maria Savino; Stefano Cacchione; Eric Gilson
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

6.  Telomeric repeats act as nucleosome-disfavouring sequences in vivo.

Authors:  Yuichi Ichikawa; Nobuyuki Morohashi; Yoshifumi Nishimura; Hitoshi Kurumizaka; Mitsuhiro Shimizu
Journal:  Nucleic Acids Res       Date:  2013-10-29       Impact factor: 16.971

7.  The human telomeric protein hTRF1 induces telomere-specific nucleosome mobility.

Authors:  Sabrina Pisano; Daniela Leoni; Alessandra Galati; Daniela Rhodes; Maria Savino; Stefano Cacchione
Journal:  Nucleic Acids Res       Date:  2010-01-07       Impact factor: 16.971

8.  Chromatin structure in telomere dynamics.

Authors:  Alessandra Galati; Emanuela Micheli; Stefano Cacchione
Journal:  Front Oncol       Date:  2013-03-07       Impact factor: 6.244

9.  Analysis of the epigenetic status of telomeres by using ChIP-seq data.

Authors:  María I Vaquero-Sedas; Chongyuan Luo; Miguel A Vega-Palas
Journal:  Nucleic Acids Res       Date:  2012-08-01       Impact factor: 16.971

10.  Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum.

Authors:  Christopher J Tonkin; Céline K Carret; Manoj T Duraisingh; Till S Voss; Stuart A Ralph; Mirja Hommel; Michael F Duffy; Liliana Mancio da Silva; Artur Scherf; Alasdair Ivens; Terence P Speed; James G Beeson; Alan F Cowman
Journal:  PLoS Biol       Date:  2009-04-14       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.